Elan

medikabazaar is a India’s pioneering and largest B2B online marketplace helping healthcare and other medical establishments in the procurement of medical supplies. We disrupted the medical supply market and leveled the playing field by launching a large-scale digital platform in 2015. With a catalog of more than 100,000 products, Medikabazaar is a single contact for purchase of medical supplies. Medikabazaar’s online platform cuts across geographical distances and enables the medical institutions in tier 2, 3 cities and remote locations in India to get quality medical supplies at competitive prices with the doorstep delivery. With its vast distribution setup, Medikabazaar aims to make last mile delivery of medical supplies available to every pin-code across India. We are presently serving 15,000+ Medical Centers; 80,000+ independent doctors and clinics across India for their regular medical supplies. We started from a one-room office in Mumbai, now we have 6 state-of-the-art regional offices and fulfillment centers spread across India. Our recent achievement includes National Icon Award 2018 for being India’s largest marketplace of medical equipment & devices.

medikabazaar is a India’s pioneering and largest B2B online marketplace helping healthcare and other medical establishments in the procurement of medical supplies. We disrupted the medical supply market and leveled the playing field by launching a large-scale digital platform in 2015. With a catalog of more than 100,000 products, Medikabazaar is a single contact for purchase of medical supplies. Medikabazaar’s online platform cuts across geographical distances and enables the medical institutions in tier 2, 3 cities and remote locations in India to get quality medical supplies at competitive prices with the doorstep delivery. With its vast distribution setup, Medikabazaar aims to make last mile delivery of medical supplies available to every pin-code across India. We are presently serving 15,000+ Medical Centers; 80,000+ independent doctors and clinics across India for their regular medical supplies. We started from a one-room office in Mumbai, now we have 6 state-of-the-art regional offices and fulfillment centers spread across India. Our recent achievement includes National Icon Award 2018 for being India’s largest marketplace of medical equipment & devices.

NewBridge Pharmaceuticals Ltd. is a specialty therapeutics company based in Dubai, United Arab Emirates, established in 2007. The company focuses on the in-licensing, acquisition, registration, and commercialization of pharmaceuticals, biologics, and medical diagnostics to meet the unmet medical needs in the Middle East, Africa, Turkey, and Caspian regions. Its product portfolio includes oncology and supportive care therapies such as Abstral, Clasteon, and Sancuso, which address pain management and chemotherapy-related symptoms. Additionally, NewBridge offers metabolic care products like Gliconorm and PYLERA, as well as CNS care therapies including Vimpat and Neupro for neurological conditions. The company also provides immunology care solutions, notably Cimzia for rheumatoid arthritis. By catering to various therapeutic areas, NewBridge Pharmaceuticals plays a vital role in enhancing healthcare outcomes in its target regions.

Proteostasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cystic fibrosis and other diseases linked to protein homeostasis. The company’s primary product candidates include PTI-801, a CFTR corrector; PTI-808, a CFTR potentiator; and PTI-428, a CFTR amplifier. Proteostasis employs theratyping to tailor treatment strategies based on individual responses to CFTR modulators, regardless of specific mutations. The company collaborates with the Cystic Fibrosis Foundation and Genentech to advance its research and development efforts. Founded in 2006 and based in Boston, Massachusetts, Proteostasis was previously known as Proteoguard, Inc. and rebranded in 2007. In December 2020, it was acquired by Yumanity Therapeutics in a reverse merger transaction.

Liposome Company manufactures commercialized drug delivery systems based on liposomes.

Athena Neurosciences is focused on the research and development of therapeutic products for neurological diseases. Athena Neurosciences was founded by Larry Bock and Lawrence Fritz.